FDA issued a Warning Letter to PCI Synthesis on 12/2/2010 for a previous inspection.
483 PolyCarbon Industries Jul 2018

483 PolyCarbon Industries Jul 2018

Robert Martin FDA$119.00 - Available Now

FDA investigators audited the PolyCarbon Industries - Newburyport, MA, United States facility and issued inspectional observations (via FDA 483) on 31 Jul 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 31 Jul 2018
  • Location: Newburyport, United States
  • FEI: 1000513517
Add To Cart